| Identification | Back Directory | [Name]
4-Hexenoic acid, 2-hydroxy-6-[(1R,4E,6E,9S,11S,12R,13R,14Z,16E,19E,21S,23S,24S)-11-hydroxy-24-(hydroxymethyl)-12,15,24-trimethyl-3-oxo-2,22,26-trioxatricyclo[19.3.1.19,13]hexacosa-4,6,14,16,19-pentaen-23-yl]-, 5-methyl-2-methylenehexyl ester, (2R,4Z)- | [CAS]
400710-51-2 | [Synonyms]
4-Hexenoic acid, 2-hydroxy-6-[(1R,4E,6E,9S,11S,12R,13R,14Z,16E,19E,21S,23S,24S)-11-hydroxy-24-(hydroxymethyl)-12,15,24-trimethyl-3-oxo-2,22,26-trioxatricyclo[19.3.1.19,13]hexacosa-4,6,14,16,19-pentaen-23-yl]-, 5-methyl-2-methylenehexyl ester, (2R,4Z)- | [Molecular Formula]
C41H60O9 | [MOL File]
400710-51-2.mol | [Molecular Weight]
696.91 |
| Hazard Information | Back Directory | [Description]
Lasonolide A is a potential anticancer molecule isolated from the marine sponge Forcepia sp., with nanomolar growth inhibitory activity and a unique cytotoxicity profile against the National Cancer Institute 60-cell-line screen |
|
|